US Stock MarketDetailed Quotes
CDTX Cidara Therapeutics
- 17.4500
- +2.3300+15.41%
Close Nov 21 16:00 ET
- 17.7500
- +0.3000+1.72%
Pre 08:00 ET
122.96MMarket Cap-753P/E (TTM)
19.9799High17.1669Low451.79KVolume18.9800Open15.1200Pre Close8.45MTurnover12.84%Turnover RatioLossP/E (Static)7.05MShares24.400052wk High1.06P/B61.41MFloat Cap10.000052wk Low--Dividend TTM3.52MShs Float382.6000Historical High--Div YieldTTM18.60%Amplitude8.0000Historical Low18.7050Avg Price1Lot Size
About Cidara Therapeutics Company
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
Company Profile
SymbolCDTX
Company NameCidara Therapeutics
Listing DateApr 15, 2015
Issue Price16.00
Founded2012
CEODr. Jeffrey Stein, PhD
MarketNASDAQ
Employees69
Fiscal Year Ends12-31
Address6310 Nancy Ridge Drive,Suite 101
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-752-6170
Websitehttp://www.cidara.com
Company Executives
- Name
- Position
- Salary
- Dr. Jeffrey Stein, PhD
- Director, President and Chief Executive Officer
- 1.56M
- Shane M. Ward
- Chief Operating Officer, Chief Legal Officer and Corporate Secretary
- 929.86K
- Leslie Tari
- Chief Scientific Officer
- --
- Dr. Preetam Shah, M.B.A.,PhD
- Chief Financial Officer, Chief Business Officer and Principal Accounting Officer
- --
- Dr. Taylor Sandison, M.D.
- Chief Medical Officer
- 884.09K
- Daniel D. Burgess
- Chairman of the Board
- 126.84K
- Ryan Spencer
- Director
- --
- Dr. Laura Tadvalkar, PhD
- Director
- --
- Dr. James Merson, PhD
- Director
- --
- Theodore R. Schroeder
- Independent Director
- 98.84K
- Dr. Bonnie L. Bassler, PhD
- Independent Director
- 86.84K
- Chrysa Mineo
- Independent Director
- 91.34K
- Carin Canale-Theakston
- Independent Director
- 82.34K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
